Topic: How To Invest

Q: Hi, Pat. What do you think about Bausch + Lomb Corp. for new buying now? Thanks.

Article Excerpt

A: Bausch + Lomb Corp., $22.01, symbol BLCO on Toronto (Shares outstanding: 351.9 million; Market cap: $7.8 billion; ir.bausch.com), was the eye care unit of Bausch Health Companies (symbol BHC on Toronto) before it was split off from its former parent and shares in the newly independent company sold to the public through an initial public offering. Bausch + Lomb launched its IPO and began trading on the Toronto and New York exchanges at $18.00 U.S. on May 6, 2022. Bausch Health Companies still owns about 88.2% of Bausch + Lomb. Bausch + Lomb has a comprehensive portfolio of over 400 products. These include contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments. The business was founded in 1853. Today, it has a over 13,000 employees and a presence in nearly 100 countries. Bausch + Lomb is headquartered in Vaughan, Ontario, with corporate offices in Bridgewater, New Jersey. Bausch + Lomb operates through three business…